Bacteria-Based Therapeutic Agents Designed to Modulate the Body’s Immune System Towards Antigen-Specific Immune Tolerance

Time: 11:30 am
day: Conference Day Two


  • Introducing the bacteria-based therapeutics platform for delivery of biologics directly to the gut
  • Showcasing its potential to modulate the body's immune system towards antigen-specific immune tolerance
  • Highlighting the phase 1b/2a study results in recent-onset Type 1 Diabetes